Tirzepatide, sold as Mounjaro for diabetes and Zepbound for weight management, is a dual agonist that engages both the GLP-1 receptor and a second incretin receptor called GIP, or glucose-dependent insulinotropic peptide
Figure 2 3.4 Association between GLP-1RA exposure and nicotine use disorder Use of GLP-1 RAs was significantly associated with a reduced odd of NUD
H tr tr bnh vim ty cp
Patients interested in accessing retatrutide should speak to their GP or a specialist, who can advise on whether any ongoing clinical trials may be appropriate and how to access them through legitimate NHS or academic research pathways
Even with perfect refrigeration
Since establishing operations in 2001, the company has developed advanced production capabilities backed by SGS laboratory testing, comprehensive certifications including cGMP and ISO22000, and a proven track record of delivering pharmaceutical-grade ingredients that meet the strictest international standards